About ANMI
ANMI is a company based in Herstal (Belgium) founded in 2015 was acquired by Telix Pharma in November 2018. The company has 20 employees as of December 31, 2021. ANMI offers products and services including Theranostic Radiopharmaceuticals and Radiopharmaceutical Services. ANMI operates in a competitive market with competitors including Laurus Labs, Sterling Pharma Solutions, Provepharm Life Solutions, Symbiotec and Jubilant Pharma, among others.
- Headquarter Herstal, Belgium
- Employees 20 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Telix Innovations
-
Annual Revenue
Not available
-
Net Profit
$101.18 K (USD)-64as on Dec 31, 2021
-
EBITDA
$1.62 M (USD)379as on Dec 31, 2021
-
Latest Funding Round
Not available
- Investors
-
Employee Count
20
as on Dec 31, 2021
-
Acquired by
Telix Pharma
(Nov 26, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ANMI
ANMI offers a comprehensive portfolio of products and services, including Theranostic Radiopharmaceuticals and Radiopharmaceutical Services.
Enables scalable synthesis for hospital-based radiopharmaceutical production.
Facilitates daily ease of radiopharmaceutical manufacturing processes.
Funding Insights of ANMI
Detailed funding history for ANMI
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in ANMI
ANMI has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Telix Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Theranostic radiopharmaceuticals are developed for cancer imaging and therapy.
|
Locked | Locked | Locked |
Investor details for ANMI
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ANMI
Investment portfolio details for ANMI
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ANMI
Detailed financials for ANMI
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Anmi Comparisons
Peer comparison for ANMI
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ANMI
ANMI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Sterling Pharma Solutions, Provepharm Life Solutions, Symbiotec and Jubilant Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company.
|
|
| Locked | Locked | Locked |
APIs are manufactured and custom synthesis services are provided.
|
Detailed competitors of ANMI
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Anmi
Complete news archive for ANMI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ANMI
ANMI was founded in 2015.
ANMI is headquartered in Herstal, Belgium. It is registered at Herstal, Liege, Belgium.
As of Dec 31, 2021, the latest employee count at ANMI is 20.
ANMI was founded in 2015 and is located in Herstal, Belgium. Operations are centered on contract development and manufacturing as a CDMO within the pharmaceutical sector. Emphasis is placed on the synthesis of active pharmaceutical ingredients (APIs). Services are extended to clients requiring specialized chemical processes, with activities based in Belgium to support European pharmaceutical needs.
ANMI's top competitors include Laurus Labs, Symbiotec and Sterling Pharma Solutions.
ANMI offers Theranostic Radiopharmaceuticals and Radiopharmaceutical Services.
ANMI has 1 investor. Key investors include Telix Pharmaceuticals.